GoldenGolden
Advanced Search
Novacyt Group

Novacyt Group

The Novacyt Group is a diagnostics company with products and services in cancer and infectious disease areas

All edits

Edits on 16 Jun, 2021
Erin Scherfner"prospector:332:162984"
Erin Scherfner edited on 16 Jun, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Country
France
Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 30 Mar, 2021
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 30 Mar, 2021
Edits made to:
Article (+6/-6 characters)
Article

Primerdesign developed a COVID-19 diagnostic test and in March, 2020 announced that it had increased manufacturing capacity to support production of 2 million COVID-19 tests per month. Novacyt is seeking FDA, Emergency Use Approval (EUA). A favourable performance assessment by Public Health England (PHE) has been reported. The test is part of the Genesig product line and is a real time PCR (RT-PCR) test that is CE-IVD marked for in vitro diagnostics in EuropeEurope.

Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
December 2014
Edits on 20 Aug, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 20 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI"Funding autocalculation"
Golden AI edited on 20 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
1,700,000
Total funding amount (USD)
5,300,000
Golden AI
Golden AI edited on 20 Aug, 2020
Edits made to:
Infobox (+1 properties)
Golden AI"Funding autocalculation"
Golden AI edited on 20 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
1,700,000
Golden AI
Golden AI edited on 20 Aug, 2020
Edits made to:
Infobox (+1 properties)
Edits on 18 Aug, 2020
Erin Scherfner"Research engine edit"
Erin Scherfner edited on 18 Aug, 2020
Edits made to:
Infobox (+1 properties)
Edits on 3 Aug, 2020
Aleksander Holm
Aleksander Holm edited on 3 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Mar, 2020
Meredith Hanel
Meredith Hanel edited on 12 Mar, 2020
Edits made to:
Categories (+1 topics)
Meredith Hanel
Meredith Hanel edited on 12 Mar, 2020
Edits made to:
Article (+140 characters)
Article

Primerdesign developed a COVID-19 diagnostic test and in March, 2020 announced that it had increased manufacturing capacity to support production of 2 million COVID-19 tests per month. Novacyt is seeking FDA, Emergency Use Approval (EUA). A favourable performance assessment by Public Health England (PHE) has been reported. The test is part of the Genesig product line and is a real time PCR (RT-PCR) test that is CE-IVD marked for in vitro diagnostics in Europe.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 12 Mar, 2020
Edits made to:
Article (+12/-12 characters)
Article

PrimerdesignPrimerdesign developed a COVID-19 diagnostic test and in March, 2020 announced that it had increased manufacturing capacity to support production of 2 million COVID-19 tests per month. Novacyt is seeking FDA, Emergency Use Approval (EUA). A favourable performance assessment by Public Health England (PHE) has been reported.

Meredith Hanel
Meredith Hanel edited on 12 Mar, 2020
Edits made to:
Infobox (+3 properties)
Description (+51/-89 characters)
Article (+1078 characters)
Topic thumbnail

Novacyt Group

The Novacyt Group is a leaderdiagnostics company with products and services in the field of cellular diagnostics with a growing portfolio of cancer and infectious disease products and servicesareas

Article

The Novacyt Group is a diagnostics company with products and services in cancer and infectious disease areas. The company engages in product development, commercialisation, contract design and manufacturing. Novacyte sells diagnostics products used in liquid based cytology (LBC), oncology, microbiology, haematology and serology. Divisions of the company include Microgen Bioproducts, which manufactures and distributes microbiology diagnostic products for clinical and food laboratories; LAB 21 Healthcare, which manufactures and supplies reagents and tests for IVD and blood grouping; Primer Design is their molecular diagnostics division which provides custom quantitative PCR (qPCR, also known as real time PCR, RT-PCR) assay development services.

...

Primerdesign developed a COVID-19 diagnostic test and in March, 2020 announced that it had increased manufacturing capacity to support production of 2 million COVID-19 tests per month. Novacyt is seeking FDA, Emergency Use Approval (EUA). A favourable performance assessment by Public Health England (PHE) has been reported.

Infobox
Founded date
2006
Golden AI
Golden AI edited on 12 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Subsidiary
Meredith Hanel
Meredith Hanel edited on 12 Mar, 2020
Edits made to:
Infobox (+1 properties)
Description (+146 characters)
Topic thumbnail

Novacyt Novacyt Group

The Novacyt Group is a leader in the field of cellular diagnostics with a growing portfolio of cancer and infectious disease products and services

Infobox
Meredith Hanel"Initial creation data"
Meredith Hanel edited on 12 Mar, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Meredith Hanel"Created via: Web app"
Meredith Hanel created this topic on 12 Mar, 2020
Edits made to:
Topic thumbnail

 Novacyt

The Novacyt Group is a diagnostics company with products and services in cancer and infectious disease areas

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.